this biotech double its price again? 7:02 a.m. July 17,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 5:50 PM

this biotech double its price again? 7:02 a.m. July 17, 2013 - The Trading Deck
This is a market that wants to go up 12:32 p.m. July 9, 2013 - The Trading Deck
For the medium-term trader, setups galore 10:39 a.m. May 14, 2013 - The Trading Deck
Transparency: Filings reveal funds like Lululemon 11:22 a.m. April 17, 2013 - Insider Monkey
S&P 500 retests the breakout point 10:01 a.m. April 15, 2013 - Michael Ashbaugh
Slow-motion uptrend nears major resistance 10:12 a.m. March 13, 2013 - Michael Ashbaugh
Nasdaq clues suggest more upward valuation 12:46 p.m. March 8, 2013 - The Trading Deck
Stocks poised to top all-time closing high 9:23 a.m. March 5, 2013 - Kate Gibson
J.C. Penney, Impax shares drop after hours 6:46 p.m. March 4, 2013 - Carla Mozee
Santarus Q4 profit triples, offers upbeat view 5:50 p.m. March 4, 2013 - MarketWatch.com
Santarus shares resume trading, rise 12% 4:38 p.m. March 4, 2013 - Carla Mozee
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Hot stocks to watch 6:31 a.m. Sept. 12, 2012 - MarketWatch.com
U.S. benchmarks violate the 200-day average 10:06 a.m. June 4, 2012 - Michael Ashbaugh
Stocks to watch Monday: AIG, AMD, BP 6:36 a.m. March 5, 2012 - MarketWatch
Medicis, PDL lead drug stocks north 11:47 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Santarus, Pharming tumble on FDA setback 10:11 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Drug indexes diverge; BioSante falls 1:00 p.m. Dec. 28, 2010 - Val Brickates Kennedy

Infinity Shares Up, Post Narrower Loss - Analyst Blog 2:40 p.m. Today - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Santarus (SNTS) Catches Eye: Stock Surges 37.6% - Analyst Blog 9:14 a.m. Nov. 11, 2013 - Zacks.com
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha
BofA Executive Nominated for Under Secretary Of Commerce and 2 Other Hot Stocks to Watch 11:47 a.m. Nov. 8, 2013 - Wall St. Cheat Sheet
Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog 11:30 a.m. Nov. 8, 2013 - Zacks.com
The Deal: Salix Pharmaceuticals Buys Santarus for $2.6B 10:50 a.m. Nov. 8, 2013 - TheStreet.com
Santarus (SNTS): Heavy Pre-Market Activity 8:28 a.m. Nov. 8, 2013 - TheStreet.com
UPDATE: Piper Jaffray Downgrades Santarus Following Salix Acquisition Announcement 8:16 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top Downgrades 6:17 a.m. Nov. 8, 2013 - benzinga.com
Santarus Pharming, Announce New Data from Open-Label Repeat Treatment Study with RUCONEST 4:55 a.m. Nov. 8, 2013 - benzinga.com
Salix Pharma to Acquire Santarus 6:18 p.m. Nov. 7, 2013 - TheStreet.com
Salix, Santarus Merging Into Billion-Dollar Drugmaker 5:38 p.m. Nov. 7, 2013 - Investors Business Daily
10-Q: SANTARUS INC 4:39 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Santarus Earnings Should Top 4 Hot Small-Cap Medicals 7:02 a.m. Nov. 7, 2013 - Investors Business Daily

Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Today - PR Newswire
Morgan & Morgan Announces the Investigation of Santarus, Inc. 4:15 p.m. Nov. 11, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Santarus, Inc. 9:10 p.m. Nov. 8, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders 4:24 p.m. Nov. 8, 2013 - BusinessWire
Law Offices of Howard G. Smith Announces Investigation of Santarus Inc. 1:38 p.m. Nov. 8, 2013 - BusinessWire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
Santarus Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Salix Pharma 11:32 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire
Law Firm Brower Piven Announces Investigation of Santarus, Inc. Proposed Buyout 9:57 a.m. Nov. 8, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Salix Pharmaceuticals, Ltd. 7:18 a.m. Nov. 8, 2013 - BusinessWire
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST 1:00 a.m. Nov. 8, 2013 - Thomson Reuters ONE
Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor) 1:00 a.m. Nov. 8, 2013 - BusinessWire

$SNTS Company News

BHP as an example against contrarian investing 8:42 a.m. Aug. 20, 2013 - The Trading Deck
4 small caps set to surge 10:29 a.m. July 24, 2013 - The Trading Deck
Can

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lung Cancer Awareness Month: United for Progress

A Concerted Effort for Lung Cancer Awareness Picture this: communities nationwide rallying together, not just to remember but to act against lung cancer. That's exactly what's happening this November, as LUNGevity Foundation spearheads Lung Cancer Awareness Month (LCAM). It’s not just about recognition—it's action with purpose. Driving Change Through Action This...

Marco's Pizza Sets Sights on Major Franchise Growth

Marco's Pizza is making waves in the franchising world, and it's not just because they're slinging dough to eager customers. You might want to pay attention to this Toledo-based dynamo as it lands yet again on the Franchise Times Top 400 list for 2026. This ranking, mind you, is no small potatoes; it's the real deal, vetted through a rigorous five-month process that spots...

ADC Therapeutics Preps Financial Results Release

ADC Therapeutics: Eyes on the Financial Prize So here we are, folks—ADC Therapeutics is blitzing the stage and gearing up to spill the beans on their third-quarter saga come November 9, 2026. Who needs a crystal ball when you've got a press release to dissect every number and nuance? Anticipating the Numbers: What's at Stake? ADC Therapeutics has been riding the wave of...

Tennessee Highlights Alarming COPD Rates This November

Tennessee Turns the Spotlight on COPD Here we are again, looking at Tennessee with its weary lung health woes. Governor Bill Lee's newest proclamation for November as COPD Awareness Month is shining a light on a crisis that's been disproportionately hitting the state harder than a sideswipe from a semi. Why the Proclamation Matters Let's cut through the fog—COPD,...

PSEG Q3 2026: Mixed Earnings Amidst Storms and Stability

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

UPM-Kymmene Finalizes Demerger: WISA Group to Nasdaq

UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....

Curaleaf Takes Stake in NJ's Boone Town Dispensary

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Big Wins for Small Operations: The Greenworks Gamble Here's something that'll make any grass-whisperer perk up. Greenworks® Commercial, known for their battery-centered machinery, juiced some serious goodwill at the Equip Exposition 2026. They coughed up nearly $34,000 in gear, dishing out prizes like really expensive candy at a lawn-care carnival. Lucky Draw Brings...

YeePay's B2B Payment Innovations Target Airlines' Pain Points

A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...

HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...